S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Adar1 Capital Management/Q2 2026

Adar1 Capital Management

Periodo: Q2 2026 · Depositato: 2026-08-14
Vedi su SEC EDGAR
AUM
$2.19B
Valore totale del portafoglio
Posizioni
277
Titoli dichiarati
Prima Posizione
ABVX
11.0% $240.5M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2026-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ABVXABIVAX SA$240.5M11.01%$133.26$118.96-10.7%
11.0%
PTGXPROTAGONIST THERAPEUTICS INC$117.8M5.39%$122.58$155.10+26.5%
5.4%
ROIVROIVANT SCIENCES LTD$111.7M5.11%$35.39$36.20+2.3%
5.1%
SPYSTATE STR SPDR S&P 500 ETF T$96.4M4.41%$746.77$776.34+4.0%
4.4%
IMVTIMMUNOVANT INC$89.8M4.11%$38.53$41.82+8.5%
4.1%
ZLABZAI LAB LTD$64.0M2.93%$19.00$25.90+36.3%
2.9%
AGIOAGIOS PHARMACEUTICALS INC$47.8M2.19%$37.11$33.56-9.6%
2.2%
CRNXCRINETICS PHARMACEUTICALS IN$45.7M2.09%$37.42$84.70+126.3%
2.1%
BOXXEA SERIES TRUST$39.5M1.81%$117.09$117.87+0.7%
1.8%
CYTKCYTOKINETICS INC$39.0M1.79%$85.19$74.13-13.0%
1.8%
SEPNSEPTERNA INC$31.5M1.44%$33.49$44.50+32.9%
1.4%
AVRANTERIS TECHNOLOGIES GLOBAL$31.0M1.42%$9.85$9.40-4.6%
1.4%
EDITEDITAS MEDICINE INC$28.8M1.32%$3.24$2.82-13.0%
1.3%
DNLIDENALI THERAPEUTICS INC$26.5M1.21%$25.72$24.40-5.1%
1.2%
SYRESPYRE THERAPEUTICS INC$25.2M1.15%$88.78$103.63+16.7%
1.1%
VIRVIR BIOTECHNOLOGY INC$25.0M1.15%$10.19$9.24-9.3%
1.1%
PRAXPRAXIS PRECISION MEDICINES I$24.9M1.14%$334.79$366.81+9.6%
1.1%
INSMINSMED INC$24.4M1.12%$106.62$123.74+16.1%
1.1%
CLDXCELLDEX THERAPEUTICS INC NEW$23.1M1.05%$37.21$41.95+12.7%
1.1%
VKTXVIKING THERAPEUTICS INC$22.4M1.02%$39.01$33.19-14.9%
1.0%
TSHATAYSHA GENE THERAPIES INC$20.7M0.95%$6.81$5.95-12.6%
0.9%
MNPRMONOPAR THERAPEUTICS INC$20.1M0.92%$92.59$113.04+22.1%
0.9%
OVIDOVID THERAPEUTICS INC$19.9M0.91%$2.69$2.83+5.2%
0.9%
ELVNENLIVEN THERAPEUTICS INC$19.7M0.90%$50.75$58.82+15.9%
0.9%
ENTAENANTA PHARMACEUTICALS INC$19.6M0.90%$14.58$13.16-9.7%
0.9%
IWMPUTISHARES TR$18.8M0.86%$300.45$305.09+1.5%
0.9%
SPYPUTSTATE STR SPDR S&P 500 ETF T$18.7M0.85%$746.77$776.34+4.0%
0.8%
NKTRNEKTAR THERAPEUTICS$17.1M0.78%$69.81$73.02+4.6%
0.8%
INSPINSPIRE MED SYS INC$16.7M0.76%$44.61$57.10+28.0%
0.8%
RVMDREVOLUTION MEDICINES INC$16.4M0.75%$187.28$203.71+8.8%
0.8%

Attività Trimestre su Trimestre

Q2 2026 vs. Q1 2026

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
EDITEDITAS MEDICINE INC$28.8M-13.0%
VORVOR BIOPHARMA INC$12.5M
SNSEFAETH THERAPEUTICS INC$9.0M
ASNDASCENDIS PHARMA A/S$7.6M
AMANAT ACQUISITION CORP$7.6M
RESEARCH ALLIANCE CORP III$7.0M
RLAYRELAY THERAPEUTICS INC$6.7M
DISCIPLINED GROWTH$5.0M

Posizioni Chiuse (8)

TickerEmittenteNozionale
TERNTERNS PHARMACEUTICALS INC$48.2M
BEAMBEAM THERAPEUTICS INC$34.5M
SRRKSCHOLAR ROCK HLDG CORP$20.0M
TERNTERNS PHARMACEUTICALS INC$10.5M
VRTXVERTEX PHARMACEUTICALS INC$6.7M
VRDNVIRIDIAN THERAPEUTICS INC$6.0M
ASNDASCENDIS PHARMA A/S$5.7M
LLYELI LILLY & CO$4.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
PRAXPRAXIS PRECISION MEDICINES I$24.4M+4850.2%+9.6%
RLYBRALLYBIO CORP$14.6M+4411.1%
ABVXCALLABIVAX SA$235.6M+4001.6%-10.7%
ENTAENANTA PHARMACEUTICALS INC$18.9M+2518.0%-9.7%
IFRXINFLARX NV$6.6M+1795.5%
CRBPCALLCORBUS PHARMACEUTICALS HLDGS$3.6M+1105.1%
FULCFULCRUM THERAPEUTICS INC$4.7M+1098.7%
BHVNBIOHAVEN LTD$7.1M+1020.4%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ABVXCALLABIVAX SA$-149.3M-96.8%-10.7%
AMLXPUTAMYLYX PHARMACEUTICALS INC$-13.2M-96.0%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$-8.0M-94.1%
MPLTMAPLIGHT THERAPEUTICS INC$-6.7M-92.9%
SNYSANOFI SA$-12.8M-82.0%
CRBPCALLCORBUS PHARMACEUTICALS HLDGS$-2.5M-81.9%
SPYPUTSTATE STR SPDR S&P 500 ETF T$-30.7M-67.1%+4.0%
CBIOCRESCENT BIOPHARMA INC.$-0.6M-63.6%
Torna agli Hedge Fund